Assessment and management of chronic hepatitis B

Infectious Disease Clinics of North America
Marc G Ghany, Edward C Doo

Abstract

An understanding of the natural history of CHB is critical for the management of the liver disease. Three clinical patterns with different clinical outcomes are recognized: HBeAg-positive CHB, HBeAg-negative CHB,and inactive CHB. Patients with elevated aminotransferase levels and HBV DNA greater than 105 viral copies per mL in serum and with features of chronic hepatitis on liver biopsy are candidates for therapy regardless of HBeAg status. Multiple host and viral factors and safety profiles of current therapies need to be considered carefully before recommending therapy. There appears to be no role for HBV genotyping in the management of patients. Three antiviral agents are approved for use against CHB infection:IFN-a, lamivudine, and adefovir. Efficacy is moderate at best and is limited by the poor tolerability of IFN and the development of resistance, coupled with concerns regarding the long-term safety with nucleoside analogs. Several new nucleoside and nucleotide analogs and novel agents are at various stages of development as potential therapies for CHB. The ideal compound would be one that is active against all replicative intermediates of the virus and has a low toxicity profile. Despite current shortcomings, the future...Continue Reading

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·S L DoongY C Cheng
Jul 3, 1991·Journal of the National Cancer Institute·B J McMahon, T London
Jul 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H HoofnagleH Popper
Sep 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S Lok, C L Lai
Jun 1, 1981·Annals of Internal Medicine·J H HoofnagleZ B Bales
Dec 1, 1995·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F Rodriguez-FriasJ Guardia
Feb 1, 1993·Annals of Internal Medicine·R de FranchisG Ronchi
Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Dec 11, 1997·The New England Journal of Medicine·W M Lee
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B C SongY S Lee
Sep 26, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B J McMahonJ Williams
Dec 22, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E OritoS Iino
Dec 29, 2000·Journal of Hepatology·J H KaoD S Chen
Oct 5, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S J Hadziyannis, D Vassilopoulos
Dec 4, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A S LokUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Apr 23, 2002·Journal of Gastroenterology and Hepatology·Varsha ThakurShiv Kumar Sarin
May 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yao-Shih HsuYun-Fan Liaw
Aug 29, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Béatrice SeignèresFabien Zoulim
Jan 10, 2003·The New England Journal of Medicine·Yves BenhamouVincent Thibault
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jules L DienstagEugene Schiff
Apr 2, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amir Shlomai, Yosef Shaul
Aug 2, 2003·Gastroenterology·Chi-Jen ChuAnna S F Lok
Oct 28, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rong-Nan ChienYun-Fan Liaw
Mar 16, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Emmet B KeeffeTeresa L Wright
Jan 11, 2005·Lancet·Harry L A JanssenUNKNOWN Rotterdam Foundation for Liver Research

❮ Previous
Next ❯

Citations

Aug 26, 2014·Infectious Disease Clinics of North America·Lindsay A PettyDonald M Jensen
Oct 31, 2008·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·Rhea J Mossman Sims, Roberta L Woodgate
Dec 18, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Philip VutienMindie H Nguyen

❮ Previous
Next ❯

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Clinics in Liver Disease
Annemarie Broderick, Maureen M Jonas
Seminars in Fetal & Neonatal Medicine
Mei-Hwei Chang
© 2021 Meta ULC. All rights reserved